FOSAMAX FEMUR FRACTURES – TV EXPOSE’
For several years, the Philadelphia product liability lawyers at Pomerantz Perlberger & Lewis have been waging a legal battle against the giant drug company, Merck, that makes and distributes its product, Fosamax. The FDA approved this drug years ago for the prevention and treatment of osteoporosis and other bone disorders, which conditions arise most prevalently in women over the age of 50. Unfortunately, as was discovered by Dr. Jennifer P. Schneider, who was a lecturer advocating the use of this product and had used it herself for a prolonged period of time with tragic consequences, the formulation of this drug created an increased risk of suffering femur fractures. Our Fosamax Femur Fracture webpage has a featured link to Dr. Schneider’s article appearing in the peer review journal known as Geriatrics reproduced in full.
Merck denies any causal connection between Fosamax and femur fractures and has been fighting the cases we have brought. Gladly, the print and television media has now begun exposing the incidents of such fractures in women using Fosamax over a long period of time. One noted Washington physician, Dr. Robert Bunning, after seeing the stark evidence of this rare fracture (where no catastrophic trauma can be implicated) appearing in patients who had been taking Fosamax over a prolonged period of time, gave an interview that was televised on local TV. Yesterday, on March 8, 2010, Diane Sawyer of ABC News reported this issue over its TV network. A link to this report can be found at:
http://abcnews.go.com/WN/WorldNews/osteoporosis-drugs-fosamax-increase-risk-broken-bones-women/story?id=10044066
If you are a victim of long-term use of Fosamax and have suffered femur fractures, please click here to contact the Fosamax Femur Fracture Attorneys at Pomerantz Perlberger & Lewis. We will get back to you promptly and, if appropriate, represent you in seeking recovery for your resulting injuries, including lost wages, pain and suffering and fear of the continued effects of this drug in your body into the future
Comments
The Fosamax (Alendronate) study done for FDA approval failed to show any benefit for the majority of the worried well, which is the osteopenia group defined as T score greater than -2.5. This Osteopenia Group actually had higher fracture rates than placebo. This was published by Cummings in JAMA in 1998.
Bisphosphonate drugs like Fosamax have severe adverse side effects of jaw necrosis (OJN), spontaneous mid-femur fracture, heart rhythm disturbances, and severe bone and joint pain.
The spontaneous mid femur fractures are especially troubling, since these are spontaneous fractures without any trauma. Subtrochanteric fractures are pathological fractures, indicating the underlying bone matrix is abnormal. This anormal weakening and brittleness is directly caused by the bisphosphonate drug.
Bottom Line: These are BAD drugs that actually make the bones weaker not stronger, and they should be banned by the FDA . However, knowing the FDA which is in the pocket of the drug companies, no action will be taken until many more women victims suffer from these drugs, and many more cases work their way through drug litigation court..
jeffrey dach md
Posted by: Jeffrey Dach MD | March 14, 2010 9:34 PM